Literature DB >> 17621476

Spinal cord demyelination associated with biotinidase deficiency in 3 Chinese patients.

Yanling Yang1, Chaoyang Li, Zhaoyue Qi, Jiangxi Xiao, Yao Zhang, Seiji Yamaguchi, Yuki Hasegawa, Yasuko Tagami, Yuwu Jiang, Hui Xiong, Yuehua Zhang, Jiong Qin, Xi-Ru Wu.   

Abstract

Biotinidase deficiency is a treatable cause of severe neurological disorders and skin problems. Spinal cord impairment is a rare complication of this disease and is commonly unrecognized. The authors encountered 3 Chinese patients with progressive spinal cord demyelination associated with biotinidase deficiency. Case 1 exhibited fatigue, proximal muscular weakness, and hypotonic paraplegia from the age of 7 years 4 months. Demyelination of cervical and thoracic cord was evident on magnetic resonance imaging (MRI). Case 2 developed visual impairment, blepharoconjunctivitis, and optic nerve atrophy from 5 years of age, which combined with progressive hypertonic paralysis, ataxia, and alopecia from the age of 7 years. His spinal MRI T2-weighted sequence revealed an extensive hyperintense lesion involving the cervical spinal cord C(2) to C(4). Bilateral optic nerves were significantly thick. In case 3, intercurrent wheezing, tachypnea, dyspnea, and lethargy occurred from the age of 1 year. Medulla and upper cervical spine edema and demyelination were found on MRI. Markedly elevated urine organic acids and decreased blood biotinidase activities were observed in the 3 patients. Biotin supplementation led to a dramatic improvement of clinical symptoms in 3 patients. The findings indicate that biotinidase deficiency should be considered in the differential diagnosis of unexplained spinal cord demyelination because prompt diagnosis and treatment with biotin may enable an excellent recovery.

Entities:  

Mesh:

Year:  2007        PMID: 17621476     DOI: 10.1177/0883073807300307

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  6 in total

1.  A Treatable Cause of Myelopathy: Biotinidase Deficiency Presenting as Acute Flaccid Paralysis.

Authors:  Vykuntaraju K Gowda; Chetan Kerur; Dhananjaya K Vamyanmane; Pragalatha Kumar; Vani H Nagarajappa; Sanjay K Shivappa
Journal:  J Pediatr Genet       Date:  2020-10-08

2.  Diagnosis, treatment, follow-up and gene mutation analysis in four Chinese children with biotinidase deficiency.

Authors:  J Ye; T Wang; L S Han; W J Qiu; H W Zhang; Y F Zhang; X L Gao; Y Wang; X F Gu
Journal:  J Inherit Metab Dis       Date:  2009-08-29       Impact factor: 4.982

3.  Optic neuritis in a child with biotinidase deficiency: case report and literature review.

Authors:  Abdul-Aziz Hayati; Wan-Hazabbah Wan-Hitam; Min-Tet Cheong; Rohaizan Yunus; Ismail Shatriah
Journal:  Clin Ophthalmol       Date:  2012-03-13

4.  Whole-Exome Sequencing Reveals a Missense Variant c.1612C>T (p.Arg538Cys) in the BTD Gene Leading to Neuromyelitis Optica Spectrum Disorder in Saudi Families.

Authors:  Muhammad Imran Naseer; Peter Natesan Pushparaj; Angham Abdulrahman Abdulkareem; Osama Y Muthaffar
Journal:  Front Pediatr       Date:  2022-02-21       Impact factor: 3.418

Review 5.  Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis.

Authors:  Silvia Tenembaum; E Ann Yeh
Journal:  Front Pediatr       Date:  2020-06-25       Impact factor: 3.418

6.  Severe Distal Motor Involvement in a Non-compliant Adult With Biotinidase Deficiency: The Necessity of Life-Long Biotin Therapy.

Authors:  Géraldine Van Winckel; Diana Ballhausen; Barry Wolf; Melinda Procter; Rong Mao; Patricie Burda; Davide Strambo; Thierry Kuntzer; Christel Tran
Journal:  Front Neurol       Date:  2020-10-26       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.